Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis

Published:2018-09-19 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Cecchinato Valentina,D'Agostino Gianluca,Raeli Lorenzo,Nerviani Alessandra,Schiraldi Milena,Danelon Gabriela,Manzo Antonio,Thelen Marcus,Ciurea Adrian,Bianchi Marco E.,Rubartelli Anna,Pitzalis Costantino,Uguccioni Mariagrazia

Funder

Seventh Framework Programme

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Novartis Stiftung für Medizinisch-Biologische Forschung

Gottfried und Julia Bangerter-Rhyner-Stiftung

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference59 articles.

1. Interleukin-1 function and role in rheumatic disease;Schett;Nat Rev Rheumatol.,2016

2. Cytokines in rheumatoid arthritis - shaping the immunological landscape;McInnes;Nat Rev Rheumatol.,2016

3. Targeting GM-CSF in inflammatory diseases;Wicks;Nat Rev Rheumatol.,2016

4. Cyclooxygenase-1 and−2 expression in rheumatoid synovial tissues;Crofford;J Clin Invest.,1994

5. Successes and failures of chemokine-pathway targeting in rheumatoid arthritis;Szekanecz;Nat Rev Rheumatol.,2016

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of Early Blood Perfusion Promotes CXCL12 Expression and Recruits Monocytes/Macrophages in Damaged Adipose Tissue in Mice Model;Aesthetic Plastic Surgery;2024-05-20

2. Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration;Frontiers in Immunology;2024-05-13

3. The Role of Alarmins in the Pathogenesis of Rheumatoid Arthritis, Osteoarthritis, and Psoriasis;Current Issues in Molecular Biology;2024-04-19

4. Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases;Redox Biology;2024-04

5. High mobility box protein-1 may be a new biomarker in active interstitial lung disease of systemic sclerosis;Journal of Clinical and Experimental Investigations;2024-03-14